MicroCME: Navigating JAK Inhibitors - Timing and Strategies for Use in Atopic Dermatitis
![]()
Price: FREE to members; $20 non-members
Length: 27 minutes
This microlearning, presented by Dr. Clinton Dunn, discusses how to determine optimal timing and strategies for incorporating JAK inhibitors into treatment plans for atopic dermatitis.
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Practicing allergists
Allied health professionals
Primary Care Providers
Fellows-in-Training
Learning Objectives
By participating in this course, learners should be able to determine optimal timing and strategies for incorporating JAK inhibitors into treatment plans for atopic dermatitis, based on an understanding of their mechanism of action, indications, and patient-specific considerations.
Reviewers
Karen M. Anstey, MD, FACAAI
Nothing relevant to disclose
Jordana Alyssa Goldman, MD
Nothing relevant to disclose
Farah Nawaz Khan, MD, FACAAI
Nothing relevant to disclose
Joel S. Klein, MD, FACAAI
Nothing relevant to disclose
Christina Grace Kwong, MD, FACAAI
Nothing relevant to disclose
Deepti Vellaichamy Manian, MD, FACAAI
Nothing relevant to disclose
Brianne Nicole Navetta-Modrov, MD, FACAAI
Nothing relevant to disclose
Deepa Patadia, MD
Nothing relevant to disclose
Tammy Peng, MD
Nothing relevant to disclose
Available Credit
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Attendance
- 0.50 CBRN

Facebook
X
LinkedIn
Forward